TMEM100 acts as a TAK1 receptor that prevents pathological cardiac hypertrophy progression.

Autor: Zhang, Bin-Bin1 (AUTHOR), Zhao, Yi-Lin2 (AUTHOR), Lu, Yan-Yu1 (AUTHOR), Shen, Ji-Hong3 (AUTHOR), Li, Hui-Yong1 (AUTHOR), Zhang, Han-Xue4 (AUTHOR), Yu, Xiao-Yue1 (AUTHOR), Zhang, Wen-Cai1 (AUTHOR), Li, Gang1 (AUTHOR), Han, Zhan-Ying1 (AUTHOR) hzy91@163.com, Guo, Sen1 (AUTHOR) fccguos@edu.zzu.com, Zhang, Xu-Tao1,5 (AUTHOR) zbbgzr@126.com
Zdroj: Cell Communication & Signaling. 9/11/2024, Vol. 22 Issue 1, p1-16. 16p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje